Vaccines for Immune Mediated Diseases


Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis BInfluenza and Pneumococcal vaccination


  • Innate immunity and diabetes vaccines
  • Central nervous system-targeted & Tissue-specific autoimmunity
  • Vaccines for immunodeficiency diseases
  • Vaccines for autoimmune skin disorders & neuropathies
  • Vaccination strategy in patients with IMID
  • Vaccine safety: impact on disease activity in IMID patients
  • Vaccinations in patients with immune-mediated inflammatory diseases

Related Conference of Vaccines for Immune Mediated Diseases

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

Vaccines for Immune Mediated Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in